PATH-21. ANGIOTENSINOGEN GENE SILENCING PREDICTS...

Neuro-Oncology 2018 / 11 Vol. 20; Iss. suppl_6

PATH-21. ANGIOTENSINOGEN GENE SILENCING PREDICTS BEVACIZUMAB RESPONSE IN RECURRENT GLIOBLASTOMA PATIENTS

Urup, Thomas, Gillberg, Linn, Michaelsen, Signe, Christensen, Ib, Broholm, Helle, Lassen, Ulrik, Groenbaek, Kirsten, Poulsen, Hans
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/noy148.677
Date:
November, 2018
File:
PDF, 123 KB
english, 2018
Conversion to is in progress
Conversion to is failed